Having a part of his spleen removed and a rare chronic disease hasn’t stopped 12-year-old E’Shon Guy from living a normal ...

Family members have called for an independent investigation into CaSandra Pearson's death, saying she belonged in a hospital ...

Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...

DCGI cleared Phase III trials of Zydus’ Desidustat for sickle cell disease. If proven safe and effective, the oral drug could offer an accessible new treatment option for millions of Indians.

Zydus Lifesciences Limited (Zydus), an innovation-led global lifesciences company, has received permission to conduct a Phase ...

This deals another blow to tebapivat’s development prospects following its May 2026 termination in MDS due to efficacy ...

Agios Pharmaceuticals said tebapivat fell short of expectations in a Phase 2 test in sickle cell disease. It’s the latest in ...

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in ...

Zydus Lifesciences Limited, an innovation-led global lifesciences company, has received permission to conduct a phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted ...

A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase (PK) activator has failed to support continued ...

WOAI NBC News Channel 4 San Antonio provides local news, weather forecasts, traffic updates, investigations, and items of ...

Zydus Lifesciences temporarily suspended some operations at its facilities in the Ahmedabad zone due to torrential rain and ...